暴露于空气中的细颗粒物会诱导类似喘标志的转录组变化:综合奥米克分析的见解
Daniel González1, Alexis Infante2, Liliana López3
1Institute of Human Genetics, School of Medicine, Pontificia Universidad Javeriana, Bogotá 110231, Colombia.
Environmental epigenetics
|January 24, 2025
概括
细颗粒物 (PM2.5) 暴露和喘在呼吸道细胞中具有共同的分子通路. 这项研究确定了共享的基因表达模式和生物过程,提供了潜在的治疗点和生物标志物.
科学领域:
- 环境健康 环境健康
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 细颗粒物 (PM2.5) 是一种有害的空气污染物,影响呼吸系统健康.
- 将PM2.5暴露与喘恶化联系在一起的分子机制尚未完全理解.
- 空气道上皮细胞是PM2.5相互作用和呼吸道疾病发展的关键地点.
研究的目的:
- 研究PM2.5暴露对人类呼吸道上皮细胞的分子影响.
- 为了确定PM2.5暴露和喘之间共享的共同分子变化.
- 发现PM2.5相关呼吸道疾病的潜在分子生物标志物和治疗点.
主要方法:
- 对公开可用的转录基因组和表观基因组数据集进行综合分析.
- 不同基因表达和H3K27ac丰富分析.
- 同表达网络分析以确定保存的生物模块和途径.
主要成果:
- 在PM2.5暴露和喘之间确定了349个常见的差异表达基因和H3K27ac相关基因.
- 揭示了与PM2.5和喘相关的三个保存的共同表达模块 (蛋白质折叠,细胞迁移,缺氧反应).
- 突出失调的途径包括上皮功能,缺氧反应和炎症信号.
- 隐含的枢纽基因 (例如,TGFB2,EFNA5,PFKFB3) 在气道重塑和细胞过程中.
结论:
- 暴露于PM2.5和喘在呼吸道上皮细胞中具有共同的分子基础.
- 已识别的分子通路和基因为PM2.5诱导的呼吸系统效应的病变产生提供了洞察力.
- 这些发现支持开发新的生物标志物和治疗空气污染相关肺部疾病的治疗策略.
- 结果强调了空气质量管理对公共卫生的重要性.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma: Pathogenesis and Management
346
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
346
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K


